Medevice Capital
Medevice is a venture capital firm based in Paris, France, founded in 2011. The firm specializes in investing in medical technology and e-health innovation projects, focusing on healthcare, digital health, and wellness sectors within the region. With a team composed of experienced entrepreneurs who have worked in healthcare companies, Medevice possesses a deep understanding of the potential of various projects. This expertise enables the firm to provide meaningful support to emerging companies as they navigate challenges in the industry.
Dyameo is a medical technology company focused on developing single-use endoscopic probes that enable the immediate detection of cancer cells. These innovative probes are designed for in-vivo diagnostics and assist medical professionals in identifying cancer cells at an early stage during endoscopic examinations. By providing a reliable tool for cancer detection, Dyameo aims to enhance the accuracy and efficiency of cancer diagnoses, ultimately contributing to improved patient outcomes.
Imactis specializes in computer-assisted interventional radiology, focusing on the development and marketing of innovative solutions that aid interventional radiologists during minimally invasive needle procedures such as biopsies, tumor ablations, vertebroplasties, infiltrations, and drainages. Its technology enhances accuracy and safety while facilitating complex procedures and reducing their duration. By simplifying multi-needle alignment and providing real-time treatment planning, Imactis' solutions help avoid critical structures and eliminate angular limitations. This ultimately enables medical institutions to achieve improved outcomes and enhance patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.